Lv2
140 积分 2023-11-25 加入
Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer
30天前
已完结
Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape
30天前
已完结
Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer
1个月前
已完结
Radiation Therapy Sensitizes a Poorly Immunogenic Breast Cancer to PD-1 Blockade
1个月前
已完结
Hyperthermia with low-dose radiotherapy for recurrent breast carcinoma
1个月前
已完结
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
1个月前
已完结
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
1个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
1个月前
已完结
Pembrolizumab for Early Triple-Negative Breast Cancer
1个月前
已完结
皖公网安备34019202002308
